Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,849 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06898359 | Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer | completed | — | 29 | Yanhong DengOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT00059930 | Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer | completed | Phase 1 | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 26, 2025 |
| NCT02882620 | Enhancing Prevention Pathways Toward Tribal Colorectal Health | completed | N/A | 1,788 | University of New MexicoOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT02895464 | Feasibility of Home-based Preoperative Exercise in Older People | completed | N/A | 23 | Karolinska InstitutetOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT03724851 | Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer | completed | Phase 1 / Phase 2 | 120 | MedPacto, Inc.INDUSTRY | 1 | Mar 25, 2025 | clinicaltrials |
| NCT05347745 | Therascreen® KRAS RGQ PCR Kit | completed | N/A | 219 | QIAGEN Gaithersburg, IncINDUSTRY | 1 | Mar 24, 2025 | clinicaltrials |
| NCT03195699 | Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers | completed | Phase 1 | 64 | Tvardi Therapeutics, IncorporatedINDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT00200200 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | completed | Phase 2 | 73 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT00545545 | Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma | completed | Phase 1 / Phase 2 | 32 | HiberCell, Inc.INDUSTRY | 1 | Mar 19, 2025 | clinicaltrials |
| NCT02649790 | Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications | completed | Phase 1 / Phase 2 | 277 | Karyopharm Therapeutics IncINDUSTRY | 5 | Mar 19, 2025 | clinicaltrials |
| NCT04256707 | Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment(SPRINT) | completed | Phase 1 / Phase 2 | 126 | Karyopharm Therapeutics IncINDUSTRY | 1 | Mar 19, 2025 | clinicaltrials |
| NCT00906997 | Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy | completed | N/A | 55,498 | Hospital Clinic of BarcelonaOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT05943288 | Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy(EuroCADe) | completed | — | 850 | Olympus Europe SE & Co. KGINDUSTRY | 4 | Mar 18, 2025 | clinicaltrials |
| NCT02698462 | Adding Family History of Colorectal Cancer to the Dutch FIT-based Screening Program | completed | N/A | 6,000 | Prof. Evelien Dekker, MD, PhDOTHER | 0 | Mar 17, 2025 | clinicaltrials |
| NCT06879197 | Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer | completed | — | 1,187 | Yanhong DengOTHER | 0 | Mar 17, 2025 | clinicaltrials |
| NCT04072198 | Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients(NIVACOR) | completed | Phase 2 | 73 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04636619 | Clinical Trial Evaluating External Evaluation and Training on the Incomplete Resection (POLIPEVA Study)(POLIPEVA) | completed | N/A | 1,920 | Hospital del Rio HortegaOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT05402592 | The Effect of Oral Carbohydrate Administration on Postoperative Well-being | completed | N/A | 50 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06596317 | Impact of Indigo Carmine Pump Spraying on the Adenoma Detection Rate | completed | N/A | 330 | Shandong UniversityOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06859125 | Comparisons of Endo-Wing-assisted Colonoscopy Versus Standard Colonoscopy in Improving Adenoma Detection Rate in Symptomatic Patients Suspected of Colorectal Cancer | completed | N/A | 192 | Universiti Kebangsaan Malaysia Medical CentreOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06865586 | A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study | completed | — | 3,326 | Asan Medical CenterOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT04276935 | Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions | completed | — | 20 | AIDS Malignancy ConsortiumNETWORK | 1 | Mar 7, 2025 | clinicaltrials |
| NCT03761017 | MGD019 DART® Protein in Unresectable/Metastatic Cancer | completed | Phase 1 | 162 | MacroGenicsINDUSTRY | 5 | Mar 6, 2025 | clinicaltrials |
| NCT05697198 | PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine(PREFER) | completed | — | 1,429 | Labcorp Corporation of America Holdings, IncINDUSTRY | 1 | Mar 6, 2025 | clinicaltrials |
| NCT05740137 | Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy | completed | N/A | 795 | Ismail GögenurOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT03829410 | Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation | completed | Phase 1 / Phase 2 | 68 | Cardiff OncologyINDUSTRY | 1 | Mar 4, 2025 | clinicaltrials |
| NCT01226979 | Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer(HDRBT) | completed | N/A | 16 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03396926 | Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer | completed | Phase 2 | 44 | University of California, San FranciscoOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03058289 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6(IT-01) | completed | Phase 1 / Phase 2 | 111 | Intensity Therapeutics, Inc.INDUSTRY | 2 | Feb 27, 2025 | clinicaltrials |
| NCT06168825 | Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention(MOM) | completed | — | 40 | Inova Health Care ServicesOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT05131815 | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | completed | N/A | 8 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06029010 | An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States(COLONGER) | completed | — | 2,326 | BayerINDUSTRY | 1 | Feb 26, 2025 | clinicaltrials |
| NCT01643070 | Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases | completed | Phase 2 | 38 | Asan Medical CenterOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT04380337 | Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | completed | Phase 2 | 38 | Stanford UniversityOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT04947020 | DataBase for Analysis of Rectal Cancer Oncological Results(BARO) | completed | — | 2,443 | Jagiellonian UniversityOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06843954 | Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer | completed | Phase 4 | 157 | Mohammed Mahmood MohammedOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT05512793 | Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 2. | completed | N/A | 260 | Fundacin Biomedica Galicia SurOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05513261 | Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 3 | completed | N/A | 857 | Fundacin Biomedica Galicia SurOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05514301 | Clinical Validation of Polydeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System | completed | N/A | 205 | Fundacin Biomedica Galicia SurOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06233253 | Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy | completed | N/A | 100 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06839508 | Comprehensive Management of Rectal Cancer(CMRC) | completed | — | 8 | Centre Hospitalier de Saint-DenisOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06707337 | Brief Self-Compassion Program in Colorectal Cancer | completed | N/A | 66 | Kübra DAKDEVİROTHER_GOV | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06305364 | Predicting Adenomatous Polyps in the Colon Using Images of a Human Tongue | completed | N/A | 426 | Jubaan Ltd.INDUSTRY | 1 | Feb 20, 2025 | clinicaltrials |
| NCT04357873 | Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations(PEVOsq) | completed | Phase 2 | 112 | UNICANCEROTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT05920980 | Effect of Lidocaine on Postoperative Pain in Elderlypatients Undergoing Colorectal Cancer Surgery | completed | N/A | 276 | West China HospitalOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT04906343 | Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia | completed | N/A | 144 | Hospital Universitario de MóstolesOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT05227261 | Early Detection of Five Common Cancers Using the ctDNA Analysing Test(K-DETEK) | completed | — | 9,057 | Gene SolutionsINDUSTRY | 1 | Feb 18, 2025 | clinicaltrials |
| NCT03190174 | Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers | completed | Phase 1 / Phase 2 | 34 | Sarcoma Oncology Research Center, LLCOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT05445245 | The Longitudinal Study of Low Anterior Resection Syndrome in Patients with Newly Diagnosed Rectal Cancer. | completed | — | 125 | Chang Gung Memorial HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05943041 | Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer | completed | Phase 1 | 9 | GILongevityINDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Mar 27, 2025source: clinicaltrials